Vaccines - Bahrain | Statista Market Forecast

The Vaccines market in Bahrain is anticipated to witness a significant growth in revenue, projected to reach US$10.39m in 2024.
This growth is expected to continue at an annual growth rate (CAGR 2024-2029) of 4.86%, leading to a market volume of US$13.17m by 2029.
It is worth noting that in global comparison, United States is expected to generate the highest revenue in the Vaccines market, amounting to US$29.12bn in 2024.
Bahrain's successful implementation of a comprehensive national immunization program has led to increased demand for vaccines and a growing market in the country.

Definition:
This market covers vaccines against infectious diseases. They help to prevent diseases, usually through active immunization. Vaccines against infectious diseases transmitted by viruses (e.g., hepatitis A and B or COVID-19) and bacteria (e.g., typhoid fever or meningococcus) are included.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Pfizer, GlaxoSmithKline, Merck & Co, Sanofi, Moderna, AstraZeneca

Vaccines against infectious diseases
Prophylactic and therapeutic vaccines
Flu vaccines
COVID-19 vaccines

Sera and gammaglobulins
Antivirals
Antibiotics

The demand for vaccines in Bahrain has been growing steadily in recent years.

Customer preferences: Bahrain has a high demand for vaccines due to the government's commitment to providing free healthcare to its citizens. The country has a well-established healthcare system that is accessible to all citizens and residents. The government has also launched several vaccination campaigns in recent years to increase awareness about the importance of vaccines and to encourage people to get vaccinated.

Trends in the market: The vaccines market in Bahrain has been growing steadily due to the increasing demand for vaccines. The country has a high vaccination rate, and the government has been investing heavily in the development and distribution of vaccines. The COVID-19 pandemic has also had a significant impact on the vaccines market in Bahrain. The government has been working closely with vaccine manufacturers to secure vaccines for its citizens and residents.

Local special circumstances: Bahrain is a small island country with a population of around 1.7 million people. The country has a high standard of living and a well-developed economy. The healthcare sector in Bahrain is highly regulated, and all healthcare providers must meet strict standards set by the government. The government also provides free healthcare to all citizens and residents, which has helped to increase the demand for vaccines.

Underlying macroeconomic factors: Bahrain has a highly developed economy, with a strong focus on the service sector. The country has a high GDP per capita, which has helped to drive demand for healthcare services, including vaccines. The government has also been investing heavily in infrastructure development, which has helped to improve access to healthcare services across the country. The country's strategic location in the Gulf region has also made it an attractive destination for international healthcare providers, which has helped to boost the vaccines market.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

As of March 2023, more than 13 billion COVID-19 vaccine doses had been administered worldwide. Wide-spread vaccine availability, increasing herd immunity, and lower case numbers led to renewed hope and a feeling of normality in 2023. However, especially during the winter seasons and with the potential emergence of new variants of the virus (like Omicron in 2021-2022), tracking of coronavirus cases repeatedly becomes a focus for the public. Thus, there is a level of uncertainty about what developments the winter season 2023/2024 might bring.